Tobradex eye drops 5 ml.

$23.00

Inflammatory eye lesions (blepharitis, keratitis, conjunctivitis) of various etiologies; treatment of infectious and inflammatory diseases of the eyes after surgery; prevention of postoperative infections; cataract; inflammatory and infectious diseases with eye injuries; prevention of infection after removal of a foreign body.

Category:

Description

Composition and form of release
Tobradex is made in eye drops and eye wax. The composition of the drug includes two active components – tobramycin and dexamethasone.
Indications
Tobradex is used in the treatment of patients who have inflammatory eye lesions of bacterial or non-bacterial etiology, such as blepharitis, keratitis and conjunctivitis without compromising the integrity of the ocular epithelium.
Tobradex is used for the prevention and treatment of infectious and inflammatory diseases of the eyes in patients who have undergone surgery, for example, removal of a foreign body or cataract.
The drug is prescribed to prevent the development of inflammatory and infectious diseases with eye injuries.
Contraindications
Tobradex is not prescribed to patients with hypersensitivity to its ingredients, as well as to those patients who have previously been diagnosed with keratitis or other eye diseases caused by mycobacterium tuberculosis, herpes virus, fungal infections and flora insensitive to tobramycin.
It makes no sense to use the drug with uncomplicated removal of a foreign body from the eye.
Tobradex in both dosage forms is not used in the treatment of children under 1 year of age.
It is recommended to responsibly treat the prescription of the drug to persons who have glaucoma or thinning of the cornea.
When treating Tobradex, you should avoid driving and driving dangerous machinery, as the drug can cause blurred and blurred vision.
Application during pregnancy and lactation
Lactation and pregnancy are considered absolute contraindications for the appointment of Tobradex.
Method of administration and dosage
Tobradex is used for instillation into the conjunctival sac. The patient should receive drops of 1 or 2 every 4 or 6 hours. At the beginning of treatment, for the first time 24 or 48 hours, the drug can be used in higher dosages: 1 or 2 drops every two hours.
When prescribing an ointment, a strip of the drug, no more than 1.5 cm long, is placed in the lower conjunctival sac from 3 to 4 times a day. To increase the effectiveness of treatment, it is recommended to combine the administration of drops and ointment.
Overdose
With prolonged use of Tobradex in high doses, patients may experience irritation of the mucous membrane of the eyes, lacrimation, conjunctival hyperemia and swelling of the eyelids.
To eliminate discomfort, the patient is advised to rinse his eyes with warm running water and prescribe symptomatic treatment.
Side effects
The use of Tobradex may be accompanied by burning, dryness and itching of the mucous membranes of the eyes and eyelids, the sensation of a foreign body in the eye and allergic reactions. In rare cases, during treatment with the drug, patients may develop cataracts, mydriasis, glaucoma and photophobia.
Storage conditions and periods
Tobradex is recommended to be stored in cool places, protected from light and out of reach of children. Shelf life of the ointment is 2 years, drops before opening the bottle – 2 years, after opening – 4 weeks.